FDA expands Adequan indications

被引：0
|
作者：
不详
机构：
来源：
LARGE ANIMAL PRACTICE | 1997年 / 18卷 / 01期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [31] FDA WARNS QUALITY OF UNDERGROUND ZALCITABINE IS POOR - ROCHE EXPANDS PREMARKETING ACCESS PROGRAMS
    不详
    CLINICAL PHARMACY, 1992, 11 (05): : 385 - 385
  • [32] US FDA review and regulation of preventive vaccines for infectious disease indications: impact of the FDA Amendments Act 2007
    Gruber, Marion F.
    EXPERT REVIEW OF VACCINES, 2011, 10 (07) : 1011 - 1019
  • [33] FDA Accelerated Approval for Malignant Hematology and Oncology Indications in the Canadian Environment
    Ho, Cheryl
    Lim, Howard J. J.
    Regier, Dean A. A.
    CURRENT ONCOLOGY, 2022, 29 (02) : 402 - 410
  • [34] Utilisation review of clopidogrel: are they used under the FDA-approved indications?
    Niruntraporn, Surachet
    Chaiyakunapruk, Nathorn
    Nathisuwan, Surakit
    Thamlikitkul, Visanu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (09) : 1031 - 1037
  • [35] Recombinant human growth hormone - One of Biotech's first products expands indications
    Pramik, MJ
    GENETIC ENGINEERING NEWS, 1999, 19 (01): : 15 - +
  • [36] BASIC TREATMENT OF EQUINE POSTTRAUMATIC ARTHRITIS AND ARTHROPATHY WITH ADEQUAN
    CIESLICKI, M
    PRAKTISCHE TIERARZT, 1991, 72 (03): : 198 - &
  • [37] Gene Therapy for the Treatment of Parkinson's Disease: The Nature of the Biologics Expands the Future Indications
    Fiandaca, Massimo S.
    Bankiewicz, Krystof S.
    Federoff, Howard J.
    PHARMACEUTICALS, 2012, 5 (06): : 553 - 590
  • [38] Toward Creating a Gold Standard of Drug Indications from FDA Drug Labels
    Khare, Ritu
    Li, Jiao
    Lu, Zhiyong
    2013 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI 2013), 2013, : 30 - 35
  • [39] FDA Approval of Orphan Drug Indications for Pediatric Patients, 2011-2023
    Kakkilaya, Apoorva
    Shahzad, Mahnum
    Bourgeois, Florence T.
    JAMA PEDIATRICS, 2025, 179 (02) : 203 - 205
  • [40] FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing
    Journal of Chinese Pharmaceutical Sciences, 2018, (02) : 138 - 138
12345